Drugs Made In America Acquisition II Corp. (DMIIU) Liabilities and Shareholders Equity (2024 - 2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Liabilities and Shareholders Equity of $505.0 million for Q4 2025, up 365643.31% year-over-year from N/an in Q4 2024, and up 0.79% quarter-over-quarter from $501.0 million in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Liabilities and Shareholders Equity for 2 consecutive years, with $505.0 million the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.96 Mn |
| Sep 30, 2025 | 501.01 Mn |
| Dec 31, 2024 | 138,064.00 |